#Sec10K
Rezolute Reports Widening Net Loss Amid Pivotal Clinical Readouts for Ersodetug: Rezolute's net loss grew to $77.6 million for fiscal 2026 as G&A costs rose sharply ahead of potential commercialization, while the company navigates a critical FDA regulatory review… #Sec10K Follow Us for more
Rezolute Reports Widening Net Loss Amid Pivotal Clinical Readouts for Ersodetug
Rezolute's net loss grew to $77.6 million for fiscal 2026 as G&A costs rose sharply ahead of potential commercialization, while the company navigates a critical FDA regulatory review following mixed Phase 3 trial results.
quantli.com
September 24, 2026 at 8:35 PM
Propanc Biopharma FY2026 10-K: Net Loss Narrows Sharply but Going Concern Doubt Persists: Propanc reduced its net loss to $18.9 million from $58.9 million a year earlier, mainly due to lower stock-based compensation, but the company remains pre-revenue with only $832,006… #Sec10K Follow Us for more
Propanc Biopharma FY2026 10-K: Net Loss Narrows Sharply but Going Concern Doubt Persists
Propanc reduced its net loss to $18.9 million from $58.9 million a year earlier, mainly due to lower stock-based compensation, but the company remains pre-revenue with only $832,006 in cash and a going concern qualification from its auditors.
quantli.com
September 25, 2026 at 9:17 PM
AMST Inc. (NurseMagic™) 10-K: Revenue Grows but Going Concern Doubt Persists: Revenue more than tripled to $364,777 and net loss narrowed to $3.1 million, but the company still warns it may lack sufficient cash to fund operations for the next twelve months. #Sec10K Follow Us for more
AMST Inc. (NurseMagic™) 10-K: Revenue Grows but Going Concern Doubt Persists
Revenue more than tripled to $364,777 and net loss narrowed to $3.1 million, but the company still warns it may lack sufficient cash to fund operations for the next twelve months.
quantli.com
September 23, 2026 at 9:15 PM
SR Bancorp FY2026: Net Interest Margin Improves but Net Income Declines Amid Non-Recurring Items: SR Bancorp grew total assets to $1.19 billion and expanded net interest margin to 3.04%, but net income fell to $3.4 million from $5.1 million due to prior-year one-time… #Sec10K Follow Us for more
SR Bancorp FY2026: Net Interest Margin Improves but Net Income Declines Amid Non-Recurring Items
SR Bancorp grew total assets to $1.19 billion and expanded net interest margin to 3.04%, but net income fell to $3.4 million from $5.1 million due to prior-year one-time gains and higher expenses.
quantli.com
September 25, 2026 at 8:23 PM
Home Federal Bancorp Posts Strong Earnings Growth as Net Interest Margin Expands in Fiscal 2026: Home Federal Bancorp's net income jumped to $6.174 million in fiscal 2026 from $3.888 million a year earlier, driven by margin expansion and controlled expenses, though credit… #Sec10K Follow Us for more
Home Federal Bancorp Posts Strong Earnings Growth as Net Interest Margin Expands in Fiscal 2026
Home Federal Bancorp's net income jumped to $6.174 million in fiscal 2026 from $3.888 million a year earlier, driven by margin expansion and controlled expenses, though credit loss provisions and non-performing assets both increased.
quantli.com
September 25, 2026 at 7:24 PM
Donaldson Company FY2026 10-K: Record Earnings Driven by Aftermarket Strength and Facet Acquisition: Donaldson delivered net sales of $3,885.6 million, up 5.3%, with net earnings rising 23.7% to $453.8 million, aided by the absence of prior-year impairment charges and… #Sec10K Follow Us for more
Donaldson Company FY2026 10-K: Record Earnings Driven by Aftermarket Strength and Facet Acquisition
Donaldson delivered net sales of $3,885.6 million, up 5.3%, with net earnings rising 23.7% to $453.8 million, aided by the absence of prior-year impairment charges and strong Mobile Solutions performance, though the Facet acquisition significantly increased debt and capital intensity.
quantli.com
September 25, 2026 at 4:12 PM
Stitch Fix Fiscal 2026: Revenue Growth Returns as Losses Narrow, But Active Clients Keep Shrinking: Stitch Fix grew revenue 6.4% to $1,348.1 million in fiscal 2026 and cut its net loss to $12.6 million from $28.8 million, even as active clients declined 1.4% and… #Sec10K Follow Us for more
Stitch Fix Fiscal 2026: Revenue Growth Returns as Losses Narrow, But Active Clients Keep Shrinking
Stitch Fix grew revenue 6.4% to $1,348.1 million in fiscal 2026 and cut its net loss to $12.6 million from $28.8 million, even as active clients declined 1.4% and macroeconomic headwinds loom for fiscal 2027.
quantli.com
September 24, 2026 at 8:18 PM
RAVE Restaurant Group FY2026 10-K: Pizza Inn Growth Offsets Pie Five Decline: RAVE Restaurant Group posted modest growth in fiscal 2026, with total revenues rising to $12.9 million and net income increasing to $2.9 million, driven by strong Pizza Inn performance that… #Sec10K Follow Us for more
RAVE Restaurant Group FY2026 10-K: Pizza Inn Growth Offsets Pie Five Decline
RAVE Restaurant Group posted modest growth in fiscal 2026, with total revenues rising to $12.9 million and net income increasing to $2.9 million, driven by strong Pizza Inn performance that offset continued contraction in the Pie Five brand.
quantli.com
September 24, 2026 at 1:22 PM
NioCorp Developments: Net Loss Widens to $48.6 Million as Company Builds $415 Million Cash Position Ahead of Elk Creek Construction Decision: NioCorp's net loss grew to $48.6 million in fiscal 2026 from $17.4 million a year earlier, driven by higher exploration spending… #Sec10K Follow Us for more
NioCorp Developments: Net Loss Widens to $48.6 Million as Company Builds $415 Million Cash Position Ahead of Elk Creek Construction Decision
NioCorp's net loss grew to $48.6 million in fiscal 2026 from $17.4 million a year earlier, driven by higher exploration spending and non-cash liability charges, while the company raised over $375 million in equity financing, boosting cash to $415.0 million.
quantli.com
September 25, 2026 at 8:58 PM
Quanome Reports Pharmaceutical Revenue Growth Offset by Write-Offs, Credit Losses, and Strategic Shift into AI Infrastructure: Continuing pharmaceutical operations grew revenue to $5.9 million (up 111.8%) with gross margin improving to 56.7%, but a $10.1 million net loss… #Sec10K Follow Us for more
Quanome Reports Pharmaceutical Revenue Growth Offset by Write-Offs, Credit Losses, and Strategic Shift into AI Infrastructure
Continuing pharmaceutical operations grew revenue to $5.9 million (up 111.8%) with gross margin improving to 56.7%, but a $10.1 million net loss from continuing operations resulted from a supplier advance write-off and a large credit loss provision on a third-party loan.
quantli.com
September 25, 2026 at 8:58 PM
Energy Storage Company Grows Revenue but Widens Losses Amid Utility-Scale Expansion: Revenue rose to $13.3 million from $8.4 million, but net loss widened to $21.5 million as the company ramped up spending on personnel, R&D, and a new utility-scale battery joint venture… #Sec10K Follow Us for more
Energy Storage Company Grows Revenue but Widens Losses Amid Utility-Scale Expansion
Revenue rose to $13.3 million from $8.4 million, but net loss widened to $21.5 million as the company ramped up spending on personnel, R&D, and a new utility-scale battery joint venture in Georgia.
quantli.com
September 23, 2026 at 8:57 PM
Cracker Barrel's FY2026: Revenue Declines, Operating Loss Emerges Amid Brand Backlash and MSBC Exit: Cracker Barrel's total revenue fell 4.7% to $3.32 billion in fiscal 2026, and the company swung to an operating loss of $12.5 million as guest traffic dropped sharply amid… #Sec10K Follow Us for more
Cracker Barrel's FY2026: Revenue Declines, Operating Loss Emerges Amid Brand Backlash and MSBC Exit
Cracker Barrel's total revenue fell 4.7% to $3.32 billion in fiscal 2026, and the company swung to an operating loss of $12.5 million as guest traffic dropped sharply amid negative brand publicity, though one-time gains helped preserve net income of $31.7 million.
quantli.com
September 25, 2026 at 3:35 PM
Trio-Tech International Fiscal 2026: Revenue Surges 72% on AI Testing Demand, but Margin Compression Drives Operating Loss: Trio-Tech's Fiscal 2026 revenue grew 72% to $62.6 million, fueled by AI-related semiconductor testing demand in Malaysia and Singapore, but gross… #Sec10K Follow Us for more
Trio-Tech International Fiscal 2026: Revenue Surges 72% on AI Testing Demand, but Margin Compression Drives Operating Loss
Trio-Tech's Fiscal 2026 revenue grew 72% to $62.6 million, fueled by AI-related semiconductor testing demand in Malaysia and Singapore, but gross margin compressed to 16.6% and the company posted a small loss from operations of $204 thousand, reversing prior-year operating income.
quantli.com
September 24, 2026 at 3:47 PM
Campbell's Fiscal 2026 10-K: Margin Pressure and Tariff Costs Drive Earnings Decline Despite Cost Savings Progress: Campbell's net sales fell 5% to $9.744 billion in 2026, with diluted EPS dropping to $1.31 from $2.01 a year ago, driven by gross margin compression from… #Sec10K Follow Us for more
Campbell's Fiscal 2026 10-K: Margin Pressure and Tariff Costs Drive Earnings Decline Despite Cost Savings Progress
Campbell's net sales fell 5% to $9.744 billion in 2026, with diluted EPS dropping to $1.31 from $2.01 a year ago, driven by gross margin compression from tariffs and cost inflation, partially offset by productivity gains and cost savings initiatives.
quantli.com
September 24, 2026 at 12:09 PM
Incannex Healthcare FY2026 10-K: Net Loss Narrows to $19.3M as Financing Losses Ease, But Cash Burn and Material Weakness Persist: Incannex reduced its net loss to $19.3 million in fiscal 2026 from $46.9 million a year earlier, mainly due to the absence of large warrant… #Sec10K Follow Us for more
Incannex Healthcare FY2026 10-K: Net Loss Narrows to $19.3M as Financing Losses Ease, But Cash Burn and Material Weakness Persist
Incannex reduced its net loss to $19.3 million in fiscal 2026 from $46.9 million a year earlier, mainly due to the absence of large warrant and debt-related losses, while ending the year with $67.7 million in cash following a $65.9 million financing inflow.
quantli.com
September 25, 2026 at 12:51 PM
Astrotech Corporation FY2026 10-K: Revenue Declines, Losses Continue Amid Strategic Pivot to Lunar Initiatives: Astrotech reported fiscal 2026 revenue of $913 thousand, down 13% year-over-year, with a net loss of $14.4 million and an accumulated deficit of approximately… #Sec10K Follow Us for more
Astrotech Corporation FY2026 10-K: Revenue Declines, Losses Continue Amid Strategic Pivot to Lunar Initiatives
Astrotech reported fiscal 2026 revenue of $913 thousand, down 13% year-over-year, with a net loss of $14.4 million and an accumulated deficit of approximately $265 million. The company raised $6.7 million via an ATM offering and is exploring strategic alternatives, including a potential sale of subsidiary 1st Detect, while pivoting toward capital-intensive Lunar Initiatives.
quantli.com
September 25, 2026 at 12:33 PM
Tamboran Resources: Pre-Revenue Beetaloo Developer Reaches First Gas Sales as Cash Position Strengthens to $219 Million: Tamboran remains a pre-revenue exploration company with no natural gas sales recognized in fiscal 2026, but net loss narrowed to $30.5 million from… #Sec10K Follow Us for more
Tamboran Resources: Pre-Revenue Beetaloo Developer Reaches First Gas Sales as Cash Position Strengthens to $219 Million
Tamboran remains a pre-revenue exploration company with no natural gas sales recognized in fiscal 2026, but net loss narrowed to $30.5 million from $39.6 million and cash grew to $219.1 million following major capital raises. First gas sales commenced in September 2026, just after fiscal year-end, marking a pivotal operational milestone.
quantli.com
September 25, 2026 at 10:28 AM
Key Tronic Reports Fiscal 2026 Net Loss of $47.8 Million Amid Revenue Decline and Tax Valuation Allowance: Key Tronic's net sales fell 17.4% to $386.7 million in fiscal 2026, with a net loss of $(47.8) million driven largely by a non-cash $28.4 million deferred tax… #Sec10K Follow Us for more
Key Tronic Reports Fiscal 2026 Net Loss of $47.8 Million Amid Revenue Decline and Tax Valuation Allowance
Key Tronic's net sales fell 17.4% to $386.7 million in fiscal 2026, with a net loss of $(47.8) million driven largely by a non-cash $28.4 million deferred tax valuation allowance and customer receivable write-offs, though the company continues restructuring its global manufacturing footprint toward Vietnam and U.S. operations.
quantli.com
September 24, 2026 at 10:07 AM
THOR Industries FY2026: Flat Revenue Masks Margin Compression Amid RV Demand Softness: THOR's net sales were roughly flat at $9.61 billion for fiscal 2026, but gross margin fell to 12.6% from 14.0% and pre-tax income dropped 19.4%, reflecting unfavorable product mix,… #Sec10K Follow Us for more
THOR Industries FY2026: Flat Revenue Masks Margin Compression Amid RV Demand Softness
THOR's net sales were roughly flat at $9.61 billion for fiscal 2026, but gross margin fell to 12.6% from 14.0% and pre-tax income dropped 19.4%, reflecting unfavorable product mix, tariff costs and weaker North American demand.
quantli.com
September 22, 2026 at 10:42 AM
Aytu BioPharma FY2026 10-K: EXXUA Launch Drives Strategic Pivot Amid Revenue Decline and Continued Losses: Aytu's net revenue fell 13.3% to $57.6 million as the company shifted focus toward launching EXXUA, its new depression drug, at the expense of legacy ADHD and… #Sec10K Follow Us for more
Aytu BioPharma FY2026 10-K: EXXUA Launch Drives Strategic Pivot Amid Revenue Decline and Continued Losses
Aytu's net revenue fell 13.3% to $57.6 million as the company shifted focus toward launching EXXUA, its new depression drug, at the expense of legacy ADHD and Pediatric products; net loss widened slightly to $14.3 million while operating cash flow turned positive.
quantli.com
September 22, 2026 at 8:27 PM
Bloomia Holdings (TULP): Goodwill Impairment and Crop Waste Drive Wider Losses Despite Debt Restructuring: Revenue was roughly flat at $48.1 million, but a non-cash goodwill impairment of $11.1 million, an intangible impairment of $2.0 million, and higher bulb costs… #Sec10K Follow Us for more
Bloomia Holdings (TULP): Goodwill Impairment and Crop Waste Drive Wider Losses Despite Debt Restructuring
Revenue was roughly flat at $48.1 million, but a non-cash goodwill impairment of $11.1 million, an intangible impairment of $2.0 million, and higher bulb costs pushed operating loss to $16.9 million. A rights offering and discounted debt settlement generated a $7.0 million gain, but covenant breaches and going-concern-adjacent liquidity pressures remain key risks.
quantli.com
September 21, 2026 at 8:04 PM
YY AI (YYAI) FY2026 10-K: Revenue Doubles to $25.8M but Swings to Operating Loss Amid Acquisition Costs and Heavy Cash Burn: Revenue grew 101% to $25.8 million driven by new AI services and advertising businesses, but surging costs pushed the company from an operating… #Sec10K Follow Us for more
YY AI (YYAI) FY2026 10-K: Revenue Doubles to $25.8M but Swings to Operating Loss Amid Acquisition Costs and Heavy Cash Burn
Revenue grew 101% to $25.8 million driven by new AI services and advertising businesses, but surging costs pushed the company from an operating profit of $6.6 million to an operating loss of $6.1 million. The company raised nearly $198 million in financing activities to fund acquisitions, including a post-year-end purchase of Best Life for up to $130 million including earn-outs.
quantli.com
September 21, 2026 at 9:52 PM
Neuphoria Therapeutics FY2026 10-K: Losses Widen Amid Pipeline Pause and Pending Scancell Merger: Neuphoria's revenue fell 92.5% to $1.2 million as its lead PTSD program was paused and clinical activities halted, driving net loss to $13.5 million and cash used in… #Sec10K Follow Us for more
Neuphoria Therapeutics FY2026 10-K: Losses Widen Amid Pipeline Pause and Pending Scancell Merger
Neuphoria's revenue fell 92.5% to $1.2 million as its lead PTSD program was paused and clinical activities halted, driving net loss to $13.5 million and cash used in operations to $12.4 million. The company is now pursuing a proposed merger with Scancell while relying on ATM equity raises to fund operations into fiscal Q2 2028.
quantli.com
September 18, 2026 at 8:32 PM
Nutanix FY2026: Revenue Grows 12%, Profitability Improves, and Massive Tax Valuation Allowance Release Boosts Net Income: Nutanix delivered total revenue of $2,853.5 million in fiscal 2026, up 12% year-over-year, with GAAP operating margin expanding to 9.6% and non-GAAP… #Sec10K Follow Us for more
Nutanix FY2026: Revenue Grows 12%, Profitability Improves, and Massive Tax Valuation Allowance Release Boosts Net Income
Nutanix delivered total revenue of $2,853.5 million in fiscal 2026, up 12% year-over-year, with GAAP operating margin expanding to 9.6% and non-GAAP operating margin reaching 23.7%. Net income surged to $1,506.8 million, driven largely by a one-time $1,208.2 million tax valuation allowance release rather than core operating performance alone.
quantli.com
September 18, 2026 at 10:32 AM
Upexi Reports Sharp Widening of Net Loss as Solana Treasury Strategy Drives Massive Unrealized Losses: Upexi's shift from a consumer products company to a Solana-focused digital asset treasury produced $17.4 million in new digital asset revenue but also a $195.1 million… #Sec10K Follow Us for more
Upexi Reports Sharp Widening of Net Loss as Solana Treasury Strategy Drives Massive Unrealized Losses
Upexi's shift from a consumer products company to a Solana-focused digital asset treasury produced $17.4 million in new digital asset revenue but also a $195.1 million unrealized loss on digital assets, pushing net loss to $246.1 million from $13.7 million a year earlier.
quantli.com
September 17, 2026 at 8:43 PM